Navigation Links
Dr. Damien Bates of Organogenesis Speaks on Regenerative Medicine for Opening Night of TEDMED Conference
Date:10/27/2009

CANTON, Mass. and SAN DIEGO, Oct. 27 /PRNewswire/ -- Organogenesis, Inc. Chief Medical Officer Dr. Damien Bates will speak on the first night of the prestigious TEDMED medical innovation conference beginning today in San Diego, Calif. Dr. Bates' speech "Where Does Replacement Skin Come From?" will outline developments in the emerging and promising field of Regenerative Medicine and discuss the transformation of patient lives.

The field of regenerative medicine has now reached the stage of translating groundbreaking science into viable product offerings. Organogenesis was the first company to successfully commercialize and mass produce living regenerative medicine products - reaching hundreds of thousands of patients in the U.S. and around the world. Its flagship product, Apligraf®, was the first regenerative medicine product to have received U.S. Food and Drug Administration (FDA) approvals to close both diabetic foot ulcers and venous leg ulcers.

Damien Bates, MD, PhD, FRACS (Plast.), is a practicing board certified plastic and reconstructive surgeon with over 12 years of clinical experience in both the U.S. and Australia. Dr. Bates holds an MD from the University of Sydney and a PhD in developmental biology from the University of Melbourne.

About TEDMED

The fifth in a series created by Marc Hodosh and Richard Saul Wurman, TEDMED celebrates conversations that demonstrate the intersection and connections between all things medical and healthcare related: from personal health to public health, devices to design and Hollywood to the hospital. Together, this encompasses more than twenty percent of America's GNP while touching everyone's life around the globe. TEDMED 2009 will take place October 27-30 in San Diego, Calif. For more information, visit www.tedmed.com.

About Regenerative Medicine

A new frontier in healthcare, regenerative medicine utilizes living human cells to repair or replace body tissue damaged by injury, disease or even the natural aging process. Regenerative medicine is a multidisciplinary field which brings together biology, medicine, and engineering to empower scientists to grow living cells, tissues and organs in the laboratory, and to safely implant them into the human body for the purposes of healing.

About Organogenesis, Inc.

Having pioneered the field, Massachusetts based Organogenesis, Inc. is a world leading regenerative medicine company focused in the areas of bio-active wound healing, oral regeneration and bio-surgery. The company's mission is to bring the medical marvel of regenerative medicine products to patients and to standardize their use in everyday medical care. For more information, visit www.organogenesis.com.

SOURCE Organogenesis, Inc.


'/>"/>
SOURCE Organogenesis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
2. Alta Bates Summit Medical Center Opens Two Warm, Supportive Patient Centers: Carol Ann Read Breast Health Center and Family Resource Center
3. Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers
4. Organogenesis, Inc. Announces Acquisition of NanoMatrix, Inc.
5. Governor Patrick Announces Life Sciences Initiative Victory With Organogenesis New Headquarters
6. Organogenesis, Inc. to Develop Regenerative Medicine Therapies for U.S. Military Battlefield Injuries
7. Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine
8. Professor K. C. Nicolaou Speaks at WuXi AppTec
9. Dr. Susan Weinschenk, Chief of Technical Staff and Services, Speaks on Neuro Web Design at Persuasive Technologies 2009 Conference and Voices That Matter Web Design Conference
10. Matthew Lehman of SPRI Clinical Trials Speaks On Designing Trials For Success At The Trout Group Investor Relations Seminar
11. Patent Attorney John Rizvi Speaks at FIME International Medical Expo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... , Oct. 10, 2017 International research firm Parks Associates ... will speak at the TMA 2017 Annual Meeting , October 11 ... in the residential home security market and how smart safety and security ... Parks Associates: ... "The residential security ...
(Date:10/10/2017)... ... 2017 , ... The Pittcon Program Committee is pleased to ... who have made outstanding contributions to analytical chemistry and applied spectroscopy. Each award ... conference and exposition for laboratory science, which will be held February 26-March 1, ...
(Date:10/9/2017)... Charlotte, N.C. (PRWEB) , ... October 09, 2017 , ... ... Purple announced Dr. Christopher Stubbs, a professor in Harvard University’s Departments of Physics and ... Dr. Stubbs was a member of the winning team for the 2015 Breakthrough Prize ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... providing advanced instruments and applications consulting for microscopy and surface analysis, Nanoscience ... application consulting, Nanoscience Analytical offers a broad range of contract analysis services ...
Breaking Biology Technology:
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/28/2017)... -- The report "Video Surveillance Market by ... Devices), Software (Video Analytics, VMS), and Service (VSaaS, Installation ... 2022", published by MarketsandMarkets, the market was valued at ... reach USD 75.64 Billion by 2022, at a CAGR ... considered for the study is 2016 and the forecast ...
Breaking Biology News(10 mins):